Qrons Inc. (QRON) Research

Qrons Inc. is a biotechnology firm dedicated to creating innovative medical solutions and advanced technologies to address neurological disorders. The company's pipeline features two key investigational therapies: QS100, a 3D-printable, implantable composite of mesenchymal stem cells (MSCs) and synthetic hydrogel, specifically engineered to treat severe penetrating brain injuries; and QS200, an injectable formulation of the MSC-synthetic hydrogel, intended for concussions and other forms of diffuse axonal damage. Established in 2016, Qrons Inc. is headquartered in Long Island City, New York. The company adopted its current name in August 2017, having previously operated as BioLabMart Inc.

Market snapshot

Symbol
QRON
Price
$0.01
Day change
-0.89%
Market cap
$199.8K
P/E ratio
-2.75x
52-week range
0.0111-0.173
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Aoxing Pharmaceutical Company, Inc. (AOXG)
  • Bioasis Technologies Inc. (BIOAF)
  • BioSyntech, Inc. (BSYI)
  • CBD Life Sciences Inc. (CBDL)
  • Eastgate Biotech Corp. (ETBI)
  • Hemagen Diagnostics, Inc. (HMGN)
  • Juva Life Inc. (JUVAF)
  • Link Reservations Inc. (LRSV)

Recent insider activity

  • Merfeld Ido — A-Award (325000 shares) on 2022-12-22
  • Meer Jonah — A-Award (325000 shares) on 2022-12-22
  • Merfeld Ido — A-Award (325000 shares) on 2021-12-22
  • Meer Jonah — A-Award (325000 shares) on 2021-12-22
  • Merfeld Ido — A-Award (325000 shares) on 2020-12-10

Open Qrons Inc. (QRON) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.